Alaunos Therapeutics approves 1-for-15 reverse stock split effective Jan 31, 2024

Alaunos Therapeutics, Inc.

Reverse split ratio of 1-for-15 approved by Board on Jan 29, 2024; effective Jan 31 at 5:00 PM ET.
Every 15 pre-split shares combine into 1 post-split share; trading begins on split-adjusted basis Feb 1 under same symbol TCRT with new CUSIP.
Stockholders authorized split ratio range (1-for-5 to 1-for-15) at June 2023 annual meeting; Board selected 1-for-15 on Jan 12, 2024.
Equiniti Trust Company appointed as exchange agent for the reverse split.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.